StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen KRYSTEXXA (pegloticase by Quarter

KRYSTEXXA (pegloticase — Uncontrolled Chronic Gout) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

Amgen KRYSTEXXA (pegloticase: $400M in Q2 2026, up 14.6% from a year earlier.

Latest, Q2 2026
400
Period ended Jun 30, 2026
Change on a year earlier
+14.6%
349 in Q2 2025
History
14 quarters
Since Q1 2023
Sources
9
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedKRYSTEXXA (pegloticase — Uncontrolled Chronic Gout) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026400+14.6%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026255+8.1%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 2025435+25.7%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 2025320+3.2%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 2025349+18.7%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 2025236+0.4%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 2024346+27.2%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 2024310–Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 2024294–Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 2024235–Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 2023272–Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 20230–Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20230–Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 20230–Form 10-Q (filed 2024-05-03) ↗

Breakdown

What makes up KRYSTEXXA (pegloticase

Cite this data

StockData. (2026). Amgen KRYSTEXXA (pegloticase ($M), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-krystexxa-ww

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.